These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23167297)
1. The cam-path forward. Kirk AD Am J Transplant; 2013 Jan; 13(1):9-10. PubMed ID: 23167297 [No Abstract] [Full Text] [Related]
2. Re: letter to the editor on "Alemtuzumab induction in renal transplantation: a meta-analysis and systemic review". Zhang X; Wang L Transpl Immunol; 2013 Mar; 28(2-3):72. PubMed ID: 23352934 [No Abstract] [Full Text] [Related]
3. Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis. Morgan RD; O'Callaghan JM; Knight SR; Morris PJ Transplantation; 2012 Jun; 93(12):1179-88. PubMed ID: 22660659 [TBL] [Abstract][Full Text] [Related]
4. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178 [TBL] [Abstract][Full Text] [Related]
13. Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction. Weissenbacher A; Hautz T; Kimelman M; Oberhuber R; Ulmer H; Bösmüller C; Maglione M; Schneeberger S J Immunol Res; 2015; 2015():985460. PubMed ID: 26171403 [TBL] [Abstract][Full Text] [Related]
14. Induction therapy in renal transplant recipients: how convincing is the current evidence? Wagner SJ; Brennan DC Drugs; 2012 Mar; 72(5):671-83. PubMed ID: 22439670 [TBL] [Abstract][Full Text] [Related]
15. Alemtuzumab induction in deceased donor kidney transplantation. Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271 [TBL] [Abstract][Full Text] [Related]
17. Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation. Uemura T; Ramprasad V; Matsushima K; Shike H; Valania T; Kwon O; Ghahramani N; Shah R; Farooq U; Khan A; Kadry Z Transplantation; 2011 Sep; 92(6):678-85. PubMed ID: 21841541 [TBL] [Abstract][Full Text] [Related]
18. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Kirk AD; Hale DA; Mannon RB; Kleiner DE; Hoffmann SC; Kampen RL; Cendales LK; Tadaki DK; Harlan DM; Swanson SJ Transplantation; 2003 Jul; 76(1):120-9. PubMed ID: 12865797 [TBL] [Abstract][Full Text] [Related]
19. Finding the right job for the tool: alemtuzumab and its role in renal transplantation. Newell KA; Cendales LC; Kirk AD Am J Transplant; 2008 Jul; 8(7):1363-4. PubMed ID: 18557735 [No Abstract] [Full Text] [Related]
20. Alemtuzumab in renal transplantation. Reviews of literature and usage in the United Kingdom. Chukwu CA; Spiers HVM; Middleton R; Kalra PA; Asderakis A; Rao A; Augustine T Transplant Rev (Orlando); 2022 Apr; 36(2):100686. PubMed ID: 35151219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]